Suspected Brazilian Purpuric Fever in a Toddler with Overwhelming Epstein‐Barr Virus Infection
Author(s) -
Michael Virata,
Nancy E. Rosenstein,
James L. Hadler,
Nancy L. Barrett,
M. L. C. Tondella,
Leonard W. Mayer,
Robbin S. Weyant,
Bertha C. Hill,
Bradley A. Perkins
Publication year - 1998
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/514988
Subject(s) - medicine , ribotyping , haemophilus influenzae , virology , rash , virus , microbiology and biotechnology , dermatology , polymerase chain reaction , biology , antibiotics , biochemistry , gene
We describe a toddler from Connecticut who developed purulent conjunctivitis, fever, and a morbilliform rash. Blood cultures were positive for Haemophilus influenzae biogroup aegyptius; further investigation was performed to assess the possibility that the illness was consistent with Brazilian purpuric fever, which, to our knowledge, has not been reported in the United States. This isolate shared morphological and some biochemical characteristics with previously studied H. influenzae biogroup aegyptius strains but differed according to slide agglutination testing, plasmid characterization, and ribotyping. Blood and tissue samples obtained during his hospitalization were also positive for Epstein-Barr virus. The child died 8 days after hospitalization. Fifty other cases of invasive H. influenzae infection were identified by active surveillance studies. Of the 49 viable surveillance isolates, 10 were biotype III (two of which had the same ribotype as the strain from our case.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom